Complement-mediated HUS revisited: evolving insights into pathophysiology, diagnosis, and treatment.

Abstract excerpt

Complement-mediated hemolytic uremic syndrome (CM-HUS), commonly referred to as atypical HUS, is a rare thrombotic microangiopathy caused by uncontrolled activation of the alternative complement pathway, typically triggered by a "two-hit" mechanism. It is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end-organ damage, most commonly affecting the kidneys. While our understanding of the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Atypical Hemolytic Uremic Syndrome
• Share to Biomarkers